InChI=1S/C18H14F3N3O2S/c1- 10- 7- 12(14- 15(25) 22- 17(27) 23- 16(14) 26) 8- 13(18(19,20) 21) 24(10) 9- 11- 5- 3- 2- 4- 6- 11/h2- 8H,9H2,1H3,(H2,22,23,25,26,27) |
MNGXUGSTRXRLNI-UHFFFAOYSA-N |
CC1=CC(=C2C(=O)NC(=S)NC2=O)C=C(N1CC3=CC=CC=C3)C(F)(F)F |
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
View more via ChEBI Ontology
Outgoing
|
5- [2- methyl- 1- (phenylmethyl)- 6- (trifluoromethyl)- 4- pyridinylidene]- 2- sulfanylidene- 1,3- diazinane- 4,6- dione
(CHEBI:112960)
is a
barbiturates
(CHEBI:22693)
|
|
|